Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Pediatric Cardiology

Biology and Genetics: The 22q11.2 Connection

At a Glance

Common arterial trunk is strongly linked to a genetic condition called 22q11.2 deletion syndrome (DiGeorge syndrome), found in 30% to 40% of cases. All infants with this heart defect should be screened, as the deletion can impact surgical recovery, calcium levels, and long-term care needs.

Common arterial trunk is more than just a physical heart defect; it is often the result of a specific interruption in a baby’s earliest development. Understanding the biological “why” behind this condition and its strong connection to genetics can help you and your medical team provide the most comprehensive care for your child.

The Role of Cardiac Neural Crest Cells

During early pregnancy, a specialized group of cells called cardiac neural crest cells (CNCCs) travels from the developing brain and neck area down to the heart [1][2]. These cells act like a construction crew responsible for building the aorticopulmonary septum—the wall that splits one large “trunk” into two separate pipes (the aorta and pulmonary artery) [3].

In common arterial trunk, this construction crew either does not arrive at the heart in the right numbers or fails to follow the correct blueprints [4]. As a result, the “septation” (splitting) never happens, leaving the single large pipe and the hole in the heart (VSD) [5].

The 22q11.2 Deletion Connection

One of the most common reasons these cells fail to do their job is a genetic change known as 22q11.2 deletion syndrome (sometimes called DiGeorge syndrome).

  • The Missing Piece: This syndrome occurs when a tiny piece of genetic material is missing from the 22nd chromosome. This missing piece contains a critical gene called TBX1, which provides the instructions for those CNCCs to build the heart properly [1][6].
  • A Frequent Link: Approximately 30% to 40% of infants with common arterial trunk are found to have the 22q11.2 deletion [7][8].
  • Mandatory Testing: Because this link is so strong, current clinical guidelines recommend that all infants diagnosed with common arterial trunk receive genetic screening for this deletion [8][9].

Impact on the Hospital Journey

Knowing whether a baby has the 22q11.2 deletion is vital because it can change what the medical team expects during the hospital stay. While the deletion does not usually change whether the initial heart surgery is successful, it can influence the recovery process [10]:

  • Calcium Management: The same cells that help build the heart also help build the parathyroid glands, which control calcium [11]. Babies with the deletion may experience hypocalcemia (low calcium), which requires close monitoring and supplements to prevent jitters or more serious issues [12][13].
  • Longer Recoveries: Research shows that infants with the deletion often have longer hospital stays and may need more time on mechanical ventilation (a breathing machine) after surgery [14][10].
  • Late Mortality Risk: While the initial surgery is generally successful, the 22q11.2 deletion has been identified as a factor that may increase the risk for “late mortality” (complications later in life), making lifelong follow-up care essential [10][9].

Understanding these links ensures that the care team is not just treating the heart, but supporting every aspect of your baby’s unique biological needs.

Common questions in this guide

Why is common arterial trunk linked to 22q11.2 deletion syndrome?
During early pregnancy, missing genetic material from the 22nd chromosome prevents special cells from properly building the wall that separates the heart's main blood vessels. This failure to divide the vessels leads to the single large trunk seen in this condition.
Should all babies with common arterial trunk get genetic testing?
Yes, current clinical guidelines strongly recommend that all infants diagnosed with this heart defect receive genetic screening. This is because about 30% to 40% of babies with common arterial trunk are found to have the 22q11.2 deletion.
How does a 22q11.2 deletion affect my baby's hospital recovery?
Babies with this genetic deletion often experience longer hospital stays and may need more time on a breathing machine after their heart surgery. They also require close monitoring to prevent and treat low calcium levels.
What is the connection between the 22q11.2 deletion and low calcium?
The same group of cells responsible for building the heart's blood vessels also helps form the parathyroid glands, which control the body's calcium levels. If the genetic deletion impairs these cells, your baby may develop low calcium and need supplements.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What genetic testing method was used to screen for the 22q11.2 deletion?
  2. 2.How will the presence of a 22q11.2 deletion change the baby's management during the hospital stay?
  3. 3.Are we monitoring my baby's calcium levels closely, and do they need supplements?
  4. 4.What other specialists should be part of the care team if the test is positive?
  5. 5.How might this deletion affect my baby’s recovery time or the risk of needing more support with breathing after surgery?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Single-cell transcriptomics uncovers a non-autonomous Tbx1-dependent genetic program controlling cardiac neural crest cell development.

    De Bono C, Liu Y, Ferrena A, et al.

    Nature communications 2023; (14(1)):1551 doi:10.1038/s41467-023-37015-9.

    PMID: 36941249
  2. 2

    Neural Crest.

    Thattaliyath BD, Firulli AB

    Advances in experimental medicine and biology 2024; (1441()):125-143 doi:10.1007/978-3-031-44087-8_6.

    PMID: 38884708
  3. 3

    The Cardiac Neural Crest Cells in Heart Development and Congenital Heart Defects.

    Erhardt S, Zheng M, Zhao X, et al.

    Journal of cardiovascular development and disease 2021; (8(8)) doi:10.3390/jcdd8080089.

    PMID: 34436231
  4. 4

    The chromatin regulator Ankrd11 controls cardiac neural crest cell-mediated outflow tract remodeling and heart function.

    Kibalnyk Y, Afanasiev E, Noble RMN, et al.

    Nature communications 2024; (15(1)):4632 doi:10.1038/s41467-024-48955-1.

    PMID: 38951500
  5. 5

    Over-expression of Fgf8 in cardiac neural crest cells leads to persistent truncus arteriosus.

    Tian A, Wang S, Wang H, et al.

    Journal of molecular histology 2021; (52(2)):351-361 doi:10.1007/s10735-021-09956-2.

    PMID: 33547543
  6. 6

    Foxc2 is required for proper cardiac neural crest cell migration, outflow tract septation, and ventricle expansion.

    Inman KE, Caiaffa CD, Melton KR, et al.

    Developmental dynamics : an official publication of the American Association of Anatomists 2018; (247(12)):1286-1296 doi:10.1002/dvdy.24684.

    PMID: 30376688
  7. 7

    22q11.2 Deletion Syndrome: Impact of Genetics in the Treatment of Conotruncal Heart Defects.

    Putotto C, Pugnaloni F, Unolt M, et al.

    Children (Basel, Switzerland) 2022; (9(6)) doi:10.3390/children9060772.

    PMID: 35740709
  8. 8

    22q11.2 deletion syndrome and congenital heart disease.

    Goldmuntz E

    American journal of medical genetics. Part C, Seminars in medical genetics 2020; (184(1)):64-72 doi:10.1002/ajmg.c.31774.

    PMID: 32049433
  9. 9

    Multicenter Analysis of Early Childhood Outcomes After Repair of Truncus Arteriosus.

    Buckley JR, Amula V, Sassalos P, et al.

    The Annals of thoracic surgery 2019; (107(2)):553-559 doi:10.1016/j.athoracsur.2018.08.094.

    PMID: 30696549
  10. 10

    22q11.2 Deletion Status Influences Resource Utilization in Infants Requiring Repair of Tetralogy of Fallot and Common Arterial Trunk.

    Ghimire LV, Devoe C, Moon-Grady AJ

    Pediatric cardiology 2020; (41(5)):918-924 doi:10.1007/s00246-020-02333-y.

    PMID: 32112115
  11. 11

    Recurrent hypocalcaemic seizures: diagnosing 22q11.2 deletion syndrome in early adulthood.

    Kannadka C, Diwan AG, Chouhan S, Koithara B

    BMJ case reports 2026; (19(1)) doi:10.1136/bcr-2025-267427.

    PMID: 41526084
  12. 12

    Palatoschisis, Schizophrenia and Hypocalcaemia: Phenotypic Expression of 22q11.2 Deletion Syndrome (DiGeorge Syndrome) in an Adult.

    van der Meijs ME, Schweitzer DH, Boom H

    European journal of case reports in internal medicine 2021; (8(4)):002411 doi:10.12890/2021_002411.

    PMID: 33987118
  13. 13

    Clinical characteristics and immunological status of patients with 22q11.2 deletion syndrome in Northern Thailand.

    Ua-Areechit T, Varnado P, Tengsujaritkul M, et al.

    Asian Pacific journal of allergy and immunology 2023; (41(1)):89-95 doi:10.12932/AP-241019-0671.

    PMID: 32416666
  14. 14

    Impact of 22q11.2 deletion syndrome on clinical and immunological status of infants with conotruncal heart defects.

    Krasnanova V, Kovacikova L, Skrak P, et al.

    Cardiology in the young 2026; 1-8 doi:10.1017/S1047951125111189.

    PMID: 41566900

This page explains the genetic and biological factors associated with common arterial trunk for educational purposes. Always consult your pediatric cardiologist and genetics team regarding your child's specific diagnosis and care plan.

Get notified when new evidence is published on Common arterial trunk.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.